These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4020412)

  • 1. Selection bias in clinical trials.
    Antman K; Amato D; Wood W; Carson J; Suit H; Proppe K; Carey R; Greenberger J; Wilson R; Frei E
    J Clin Oncol; 1985 Aug; 3(8):1142-7. PubMed ID: 4020412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma.
    Lerner HJ; Amato DA; Savlov ED; DeWys WD; Mittleman A; Urtasun RC; Sobel S; Shiraki M
    J Clin Oncol; 1987 Apr; 5(4):613-7. PubMed ID: 3549990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
    Omura GA; Blessing JA; Major F; Lifshitz S; Ehrlich CE; Mangan C; Beecham J; Park R; Silverberg S
    J Clin Oncol; 1985 Sep; 3(9):1240-5. PubMed ID: 3897471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.
    Antman K; Suit H; Amato D; Corson J; Wood W; Proppe K; Harmon D; Carey R; Greenberger J; Blum R
    J Clin Oncol; 1984 Jun; 2(6):601-8. PubMed ID: 6374055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
    Alvegård TA; Sigurdsson H; Mouridsen H; Solheim O; Unsgaard B; Ringborg U; Dahl O; Nordentoft AM; Blomqvist C; Rydholm A
    J Clin Oncol; 1989 Oct; 7(10):1504-13. PubMed ID: 2674336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of adjuvant chemotherapy in head and neck cancer.
    Taylor SG; Applebaum E; Showel JL; Norusis M; Holinger LD; Hutchinson JC; Murthy AK; Caldarelli DD
    J Clin Oncol; 1985 May; 3(5):672-9. PubMed ID: 3889230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite randomization designs for clinical trials.
    Simon R
    Biometrics; 1981 Dec; 37(4):723-31. PubMed ID: 7337792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
    Holmes EC; Gail M
    J Clin Oncol; 1986 May; 4(5):710-5. PubMed ID: 3009726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.
    Chang AE; Kinsella T; Glatstein E; Baker AR; Sindelar WF; Lotze MT; Danforth DN; Sugarbaker PH; Lack EE; Steinberg SM
    J Clin Oncol; 1988 Sep; 6(9):1491-500. PubMed ID: 3047339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
    Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH
    J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.
    Levi JA; Fox RM; Tattersall MH; Woods RL; Thomson D; Gill G
    J Clin Oncol; 1986 Sep; 4(9):1348-55. PubMed ID: 3528404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations.
    Gherlinzoni F; Bacci G; Picci P; Capanna R; Calderoni P; Lorenzi EG; Bernini M; Emiliani E; Barbieri E; Normand A
    J Clin Oncol; 1986 Apr; 4(4):552-8. PubMed ID: 3514804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log.
    Hunter CP; Frelick RW; Feldman AR; Bavier AR; Dunlap WH; Ford L; Henson D; Macfarlane D; Smart CR; Yancik R
    Cancer Treat Rep; 1987 Jun; 71(6):559-65. PubMed ID: 3581095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound complications in the multimodality treatment of extremity and superficial truncal sarcomas.
    Arbeit JM; Hilaris BS; Brennan MF
    J Clin Oncol; 1987 Mar; 5(3):480-8. PubMed ID: 3819810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
    Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
    J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
    Vinciguerra V; Propert KJ; Coleman M; Anderson JR; Stutzman L; Pajak TF; Nissen NI; Frizzera G; Gottlieb A; Holland JF
    J Clin Oncol; 1986 Jun; 4(6):838-46. PubMed ID: 2423652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.